Emmaus Life Sciences, Inc. Liquidation Value

EMMA Other

Cash & Equivalents

$2.13M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $2.13M
Total Obligations: -$97.96M
$-95.83M
Per share: $-1.37
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $2.13M
AR: $2.80M
Total Obligations: -$97.96M
$-93.03M
Per share: $-1.33
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $2.13M
AR: $2.80M
Inventory: $1.55M
Total Obligations: -$97.96M
$-91.47M
Per share: $-1.30
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-95.83M$-1.37
Liquid Liquidation Value$-93.03M$-1.33
Operating Liquidation Value$-91.47M$-1.30

Key Components (as of 2025-12-31)

Cash & Equivalents$2.13M
Accounts Receivable$2.80M
Inventory$1.55M
Current Liabilities$69.07M
Long-term Debt$27.13M
Op. Lease Liability$1.76M
Finance LeaseN/A
Shares Outstanding70.2M

Explore all 159 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$2.13M$2.80M$1.55M$5.98M$69.07M$27.13M$1.76MN/A
2025-09-30$293,000$2.62M$1.21M$5.36M$64.17M$29.07M$1.85MN/A
2025-06-30$886,000$2.07M$1.31M$4.56M$62.08M$29.73M$1.93MN/A
2025-03-31$1.33M$2.06M$1.44M$4.81M$64.92M$29.01M$3.22MN/A
2024-12-31$1.39M$2.62M$1.64M$5.17M$63.55M$28.96M$3.24MN/A
2024-09-30$1.25M$4.94M$1.61M$6.49M$64.13M$29.30M$3.40MN/A
2024-06-30$1.52M$4.60M$1.63M$7.21M$64.03M$29.37M$2.23MN/A
2024-03-31$1.71M$2.99M$1.53M$6.57M$62.43M$29.44M$2.43MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-31 View
2025-09-30 10-Q 2025-11-14 View
2025-06-30 10-Q 2025-08-14 View
2025-03-31 10-Q 2025-05-15 View
2024-12-31 10-K 2025-04-14 View
2024-09-30 10-Q 2024-11-19 View
2024-06-30 10-Q 2024-09-10 View
2024-03-31 10-Q 2024-09-10 View

Community Notes

Loading notes...

Questions

Loading questions...